腎不全の世界市場レポート 2025年

腎不全市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.4％で186億8,000万米ドルに成長します。予測期間における成長の背景には、急性腎障害（AKI）の有病率の上昇、在宅治療オプションの採用増加、ヘルスケア支出の急増、研究開発投資の拡大などがあります。主な動向には、医療技術の進歩、治療オプションの革新、個別化医療の統合、透析技術の改善、新しく革新的な薬剤の開発などがあります。

高血圧と糖尿病の有病率の上昇は、今後数年間の腎不全市場の成長を牽引すると予想されます。これらの疾患は、食生活の乱れ、運動不足、肥満、遺伝的素因、高齢化などの要因によって影響を受ける。高血圧は瘢痕化と濾過能力の低下によって腎血管にダメージを与え、糖尿病は血糖値の上昇によって腎血管を肥厚させ酷使します。どちらの病態も腎臓のダメージを加速させ、最終的に腎不全をもたらします。例えば、2024年5月、英国の政府機関である国民保健サービス（NHS）は、2023年12月の南東部における高血圧診断患者数が7万1,120人増加し、2022年12月と比較して5.4％増加したと報告しました。さらに、英国を拠点とする慈善団体である英国糖尿病協会は2023年4月、英国で430万人が糖尿病と診断されたと発表しました。その結果、高血圧と糖尿病の有病率の増加が腎不全市場の拡大に拍車をかけています。

腎不全市場の主要企業は、糖尿病および慢性腎臓病（CKD）患者の腎臓および心血管合併症に対処するため、グルカゴン様ペプチド-1受容体作動薬（GLP-1 RA）の開発に注力しています。これらの薬剤は、グルコースコントロールを強化し、炎症を抑え、腎臓における酸化ストレスを低下させることにより、腎不全の進行を遅らせる。例えば、2025年1月、デンマークに本社を置く製薬会社Novo Nordisk社は、2型糖尿病とCKDを有する成人における腎臓病の進行、腎不全、心血管死のリスクを低減するオゼンピック（セマグルチド）のFDA（食品医薬品局）承認を取得しました。この承認は、糖尿病とアンメット・メディカル・ニーズを満たす進行性CKD患者に対する二重のアプローチを提供するGLP-1 RAの役割が高まっていることを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腎不全 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腎不全市場：成長率分析
• 世界の腎不全市場の実績：規模と成長, 2019-2024
• 世界の腎不全市場の予測：規模と成長, 2024-2029, 2034F
• 世界腎不全総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腎不全市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 透析
• 腎臓移植
• その他の治療の種類
• 世界の腎不全市場病気のステージ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性腎臓病（CKD）のステージ
• 末期腎疾患（ESRD）
• 世界の腎不全市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の腎不全市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 透析センター
• 病院と診療所
• 調査・学術機関
• 世界の腎不全市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンジオテンシン変換酵素（ACE）阻害剤
• アンジオテンシンII受容体拮抗薬（ARB）
• 利尿剤
• 赤血球造血刺激因子製剤（ESA）
• リン酸結合剤
• 重炭酸ナトリウム
• 世界の腎不全市場、透析の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液透析
• 腹膜透析
• 在宅透析
• 持続的腎代替療法（CRRT）
• 世界の腎不全市場腎臓移植の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生体腎移植
• 脳死ドナーによる腎臓移植
• 腎移植免疫抑制療法
• 世界の腎不全市場、その他の治療タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ライフスタイルと食生活の改善
• 幹細胞療法
• 遺伝子治療

第7章 地域別・国別分析

• 世界の腎不全市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腎不全市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腎不全市場：競合情勢
• 腎不全市場：企業プロファイル
  • Kaiser Permanente Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic plc
• Amgen Inc.
• Asahi Kasei Medical Co. Ltd.
• Fujifilm Holdings Corporation
• Fresenius Medical Care
• Toray Industries Inc.
• Baxter International Inc.
• Boehringer Ingelheim
• DaVita Inc.
• Eisai Co. Ltd.
• Nipro Corporation
• Biocon Limited
• HemoCue AB
• Rockwell Medical
• Mitsubishi Tanabe Pharma Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腎不全市場2029：新たな機会を提供する国
• 腎不全市場2029：新たな機会を提供するセグメント
• 腎不全市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Renal insufficiency refers to the decreased ability of the kidneys to filter waste products and maintain fluid and electrolyte balance in the body. It can result from chronic conditions such as diabetes, hypertension, or acute kidney injury, leading to toxin buildup in the blood. If left untreated, renal insufficiency may progress to chronic kidney disease (CKD) or kidney failure, necessitating dialysis or transplantation.

The primary treatment options for renal insufficiency include medications, dialysis, kidney transplantation, and other interventions. Medications help manage symptoms, slow disease progression, and address complications such as high blood pressure, diabetes, and anemia. The condition progresses through different stages, including chronic kidney disease (CKD) stages and end-stage renal disease (ESRD). Treatment is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, with end-users including dialysis centers, hospitals, clinics, and research and academic institutes.

The renal insufficiency market research report is one of a series of new reports from The Business Research Company that provides renal insufficiency market statistics, including renal insufficiency industry global market size, regional shares, competitors with a renal insufficiency market share, detailed renal insufficiency market segments, market trends and opportunities, and any further data you may need to thrive in the renal insufficiency industry. This renal insufficiency market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The renal insufficiency market size has grown rapidly in recent years. It will grow from $10.87 billion in 2024 to $12.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to the rising cases of high blood pressure and diabetes, the increasing prevalence of chronic kidney disease (CKD), a higher occurrence of urinary tract obstructions, an aging population, and greater awareness and education about kidney health.

The renal insufficiency market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to the rising prevalence of acute kidney injuries (AKI), increasing adoption of home-based treatment options, a surge in healthcare expenditure, and greater investments in research and development. Key trends include advancements in medical technology, innovations in treatment options, the integration of personalized medicine, improvements in dialysis technology, and the development of new and innovative medications.

The rising prevalence of high blood pressure and diabetes is expected to drive the growth of the renal insufficiency market in the coming years. These conditions are influenced by factors such as poor diet, lack of physical activity, obesity, genetic predisposition, and an aging population. High blood pressure damages kidney blood vessels by causing scarring and reducing filtration capacity, while diabetes leads to thickened and overworked kidney vessels due to elevated blood sugar levels. Both conditions accelerate kidney damage, ultimately resulting in renal insufficiency. For example, in May 2024, the National Health Service (NHS), a UK-based government agency, reported that the number of high blood pressure diagnoses in the South East increased by 71,120 patients in December 2023, marking a 5.4% rise compared to December 2022. Additionally, in April 2023, the British Diabetic Association, a UK-based charity organization, stated that 4.3 million people in the UK had been diagnosed with diabetes. Consequently, the increasing prevalence of high blood pressure and diabetes is fueling the expansion of the renal insufficiency market.

Leading companies in the renal insufficiency market are focusing on the development of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to address renal and cardiovascular complications in patients with diabetes and chronic kidney disease (CKD). These medications enhance glucose control, reduce inflammation, and lower oxidative stress in the kidneys, thereby slowing the progression of renal insufficiency. For example, in January 2025, Novo Nordisk, a Denmark-based pharmaceutical company, received Food and Drug Administration (FDA) approval for Ozempic (semaglutide) to reduce the risk of kidney disease progression, kidney failure, and cardiovascular death in adults with type 2 diabetes and CKD. This approval underscores the growing role of GLP-1 RAs in providing a dual approach to managing diabetes and renal insufficiency, addressing key unmet medical needs for patients with progressive CKD.

In February 2023, AstraZeneca PLC, a UK-based pharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. This acquisition enhances AstraZeneca's cardiorenal portfolio by incorporating baxdrostat (CIN-107), an aldosterone synthase inhibitor designed to lower blood pressure in patients with treatment-resistant hypertension. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company focused on developing treatments for individuals with moderate to severe renal impairment or kidney failure.

Major players in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation, and Sorin Group.

North America was the largest region in the renal insufficiency market in 2024. The regions covered in renal insufficiency report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the renal insufficiency market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The renal insufficiency market consists of sales of dialysis equipment, renal replacement therapies, kidney transplantation services, and pharmaceutical treatments for managing kidney function. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Renal Insufficiency Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on renal insufficiency market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for renal insufficiency ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The renal insufficiency market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Medications; Dialysis; Kidney Transplantation; Other Treatment Types
• 2) By Disease Stage: Chronic Kidney Disease (CKD) Stages; End-Stage Renal Disease (ESRD)
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By End-User: Dialysis Centers; Hospital And Clinics; Research And Academic Institutes
• Subsegments:
• 1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Diuretics; Erythropoiesis-Stimulating Agents (ESAs); Phosphate Binders; Sodium Bicarbonate
• 2) By Dialysis: Hemodialysis; Peritoneal Dialysis; Home Dialysis; Continuous Renal Replacement Therapy (CRRT)
• 3) By Kidney Transplantation: Living Donor Kidney Transplant; Deceased Donor Kidney Transplant; Kidney Transplant Immunosuppressive Therapy
• 4) By Other Treatment Types: Lifestyle And Dietary Modifications; Stem Cell Therapy; Gene Therapy
• Companies Mentioned:Kaiser Permanente; Johnson & Johnson; Roche Holding AG; Sanofi S.A.; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Renal Insufficiency Market Characteristics

3. Renal Insufficiency Market Trends And Strategies

4. Renal Insufficiency Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Renal Insufficiency Growth Analysis And Strategic Analysis Framework

• 5.1. Global Renal Insufficiency PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Renal Insufficiency Market Growth Rate Analysis
• 5.4. Global Renal Insufficiency Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Renal Insufficiency Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Renal Insufficiency Total Addressable Market (TAM)

6. Renal Insufficiency Market Segmentation

• 6.1. Global Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Dialysis
• Kidney Transplantation
• Other Treatment Types
• 6.2. Global Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Kidney Disease (CKD) Stages
• End-Stage Renal Disease (ESRD)
• 6.3. Global Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Renal Insufficiency Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dialysis Centers
• Hospital And Clinics
• Research And Academic Institutes
• 6.5. Global Renal Insufficiency Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Angiotensin-Converting Enzyme (ACE) Inhibitors
• Angiotensin II Receptor Blockers (ARBs)
• Diuretics
• Erythropoiesis-Stimulating Agents (ESAs)
• Phosphate Binders
• Sodium Bicarbonate
• 6.6. Global Renal Insufficiency Market, Sub-Segmentation Of Dialysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemodialysis
• Peritoneal Dialysis
• Home Dialysis
• Continuous Renal Replacement Therapy (CRRT)
• 6.7. Global Renal Insufficiency Market, Sub-Segmentation Of Kidney Transplantation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Living Donor Kidney Transplant
• Deceased Donor Kidney Transplant
• Kidney Transplant Immunosuppressive Therapy
• 6.8. Global Renal Insufficiency Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lifestyle And Dietary Modifications
• Stem Cell Therapy
• Gene Therapy

7. Renal Insufficiency Market Regional And Country Analysis

• 7.1. Global Renal Insufficiency Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Renal Insufficiency Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Renal Insufficiency Market

• 8.1. Asia-Pacific Renal Insufficiency Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Renal Insufficiency Market

• 9.1. China Renal Insufficiency Market Overview
• 9.2. China Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Renal Insufficiency Market

• 10.1. India Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Renal Insufficiency Market

• 11.1. Japan Renal Insufficiency Market Overview
• 11.2. Japan Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Renal Insufficiency Market

• 12.1. Australia Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Renal Insufficiency Market

• 13.1. Indonesia Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Renal Insufficiency Market

• 14.1. South Korea Renal Insufficiency Market Overview
• 14.2. South Korea Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Renal Insufficiency Market

• 15.1. Western Europe Renal Insufficiency Market Overview
• 15.2. Western Europe Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Renal Insufficiency Market

• 16.1. UK Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Renal Insufficiency Market

• 17.1. Germany Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Renal Insufficiency Market

• 18.1. France Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Renal Insufficiency Market

• 19.1. Italy Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Renal Insufficiency Market

• 20.1. Spain Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Renal Insufficiency Market

• 21.1. Eastern Europe Renal Insufficiency Market Overview
• 21.2. Eastern Europe Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Renal Insufficiency Market

• 22.1. Russia Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Renal Insufficiency Market

• 23.1. North America Renal Insufficiency Market Overview
• 23.2. North America Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Renal Insufficiency Market

• 24.1. USA Renal Insufficiency Market Overview
• 24.2. USA Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Renal Insufficiency Market

• 25.1. Canada Renal Insufficiency Market Overview
• 25.2. Canada Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Renal Insufficiency Market

• 26.1. South America Renal Insufficiency Market Overview
• 26.2. South America Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Renal Insufficiency Market

• 27.1. Brazil Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Renal Insufficiency Market

• 28.1. Middle East Renal Insufficiency Market Overview
• 28.2. Middle East Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Renal Insufficiency Market

• 29.1. Africa Renal Insufficiency Market Overview
• 29.2. Africa Renal Insufficiency Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Renal Insufficiency Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Renal Insufficiency Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Renal Insufficiency Market Competitive Landscape And Company Profiles

• 30.1. Renal Insufficiency Market Competitive Landscape
• 30.2. Renal Insufficiency Market Company Profiles
  • 30.2.1. Kaiser Permanente Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Renal Insufficiency Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Amgen Inc.
• 31.3. Asahi Kasei Medical Co. Ltd.
• 31.4. Fujifilm Holdings Corporation
• 31.5. Fresenius Medical Care
• 31.6. Toray Industries Inc.
• 31.7. Baxter International Inc.
• 31.8. Boehringer Ingelheim
• 31.9. DaVita Inc.
• 31.10. Eisai Co. Ltd.
• 31.11. Nipro Corporation
• 31.12. Biocon Limited
• 31.13. HemoCue AB
• 31.14. Rockwell Medical
• 31.15. Mitsubishi Tanabe Pharma Corporation

32. Global Renal Insufficiency Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Renal Insufficiency Market

34. Recent Developments In The Renal Insufficiency Market

35. Renal Insufficiency Market High Potential Countries, Segments and Strategies

• 35.1 Renal Insufficiency Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Renal Insufficiency Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Renal Insufficiency Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer